References
Veronese N, Cooper C, Bruyere O, Al-Daghri NM, Branco J, Cavalier E, et al. Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patient expectations. Drugs. 2022;82(13):1347–55.
Wang Q, Chen Q, Sui J, Tu Y, Guo X, Li F. Celecoxib prevents tumor necrosis factor-alpha (TNF-alpha)-induced cellular senescence in human chondrocytes. Bioengineered. 2021;12(2):12812–20.
Abrams GD, Chang W, Dragoo JL. In vitro chondrotoxicity of nonsteroidal anti-inflammatory drugs and opioid medications. Am J Sports Med. 2017;45(14):3345–50.
Liu B, Ji C, Shao Y, Liang T, He J, Jiang H, et al. Etoricoxib decreases subchondral bone mass and attenuates biomechanical properties at the early stage of osteoarthritis in a mouse model. Biomed Pharmacother. 2020;127: 110144.
Perry TA, Wang X, Nevitt M, Abdelshaheed C, Arden N, Hunter DJ. Association between current medication use and progression of radiographic knee osteoarthritis: data from the osteoarthritis initiative. Rheumatology (Oxford). 2021;60(10):4624–32.
Simic M, Harmer AR, Agaliotis M, Nairn L, Bridgett L, March L, et al. Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study. Arthritis Res Ther. 2021;23(1):160.
Toda K. Intra-articular non-steroidal anti-inflammatory drugs may promote cartilage degeneration. J Clin Pharm Ther. 2022;47(9):1491.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest/Competing interests
KT’s child is an employee of Nippon Zoki Pharmaceutical Co., Ltd.
Ethics approval
Not required for this article type.
Data and code availability statement
N/A.
Author contributions
KT is the only author.
Rights and permissions
About this article
Cite this article
Toda, K. Comment on: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs 82, 1511–1512 (2022). https://doi.org/10.1007/s40265-022-01792-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-022-01792-2